Direct oral anticoagulants versus warfarin in patients with single antibody-positive anti-phospholipid syndrome.

Angela LiuKarishma Vijay RupaniLeonard Naymagon

Published in: European journal of haematology (2022)

These findings suggest that DOACs may be a safe and effective option for patients with single-positive APLS. Prospective studies are needed to confirm these findings.

Keyphrases

direct oral anticoagulants
venous thromboembolism
atrial fibrillation
fatty acid
oral anticoagulants